First linezolid-resistant clinical isolates of Mycobacterium tuberculosis - Wikidata - awgldk - TriplyDB

First linezolid-resistant clinical isolates of Mycobacterium tuberculosis

First linezolid-resistant clinical isolates of Mycobacterium tuberculosis

http://www.wikidata.org/entity/Q35758951

about

Genome sequencing of linezolid-resistant Streptococcus pneumoniae mutants reveals novel mechanisms of resistance Rapid first- and second-line drug susceptibility assay for Mycobacterium tuberculosis isolates by use of quantitative PCR.The future of molecular diagnostics for drug-resistant tuberculosis.Comparative study for determination of Mycobacterium tuberculosis susceptibility to first- and second-line antituberculosis drugs by the Etest using 7H11, blood, and chocolate agar Linezolid for treatment of chronic extensively drug-resistant tuberculosis.Tuberculosis diagnostics in 2015: landscape, priorities, needs, and prospects rplC T460C identified as a dominant mutation in linezolid-resistant Mycobacterium tuberculosis strains.Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis complex isolated in Taiwan over 10 years.New drugs and regimens for treatment of TB.Multidrug- and extensively drug-resistant tuberculosis, Germany.New drugs and vaccines for drug-resistant Mycobacterium tuberculosis infections.Antimicrobial efflux pumps and Mycobacterium tuberculosis drug tolerance: evolutionary considerations.Mycobacterium tuberculosis: drug resistance and future perspectives.Is repositioning of drugs a viable alternative in the treatment of tuberculosis?Emerging drugs and alternative possibilities in the treatment of tuberculosis.Drug Resistance Mechanisms in Mycobacterium tuberculosis.Linezolid in the treatment of drug-resistant tuberculosis: the challenge of its narrow therapeutic index.Linezolid: a promising option in the treatment of Gram-positives.Mycobacterium tuberculosis Mutations Associated with Reduced Susceptibility to Linezolid.Efflux-pump-derived multiple drug resistance to ethambutol monotherapy in Mycobacterium tuberculosis and the pharmacokinetics and pharmacodynamics of ethambutol.In vitro isolation and characterization of oxazolidinone resistant Mycobacterium tuberculosis.Linezolid Dose That Maximizes Sterilizing Effect While Minimizing Toxicity and Resistance Emergence for Tuberculosis.Role of the Cys154Arg Substitution in Ribosomal Protein L3 in Oxazolidinone Resistance in Mycobacterium tuberculosis.Novel ribosomal mutations in Staphylococcus aureus strains identified through selection with the oxazolidinones linezolid and torezolid (TR-700).Susceptibility testing of extensively drug-resistant and pre-extensively drug-resistant Mycobacterium tuberculosis against levofloxacin, linezolid, and amoxicillin-clavulanate.In vitro-selected linezolid-resistant Mycobacterium tuberculosis mutants.Evolution of drug resistance in Mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care.Emerging drugs and drug targets against tuberculosis.

P2860

Q24655140-4763DE23-F26E-4699-9408-1C8CD90F8E7D Q30431597-C98F1F21-0D73-4389-8DD5-725C0067390C Q30455525-23FF048E-BCDB-4C97-A3C4-23D4AF251591 Q34599178-DEAEF06F-4DF4-42E2-B1F7-4A427885AE96 Q34644127-EFB47E2B-BD68-42B4-B1A9-FAB79E635FB1 Q35197235-850B8423-BF62-493D-AE58-81ED091C9973 Q35941267-5138E472-3405-4EAD-A065-51B81F4D26CA Q36156072-7AFCAFC6-FDAC-47CE-A92E-25542097465D Q36703055-C651248E-D988-4163-B529-2DA7DA534D91 Q36825354-64AAD808-01E5-44B3-BB50-BFB1536D3250 Q37072346-69748893-2382-4FCE-8B11-728958EF2506 Q37150326-55B43704-5B26-45C6-A6EE-7BAB7864038C Q37385024-E88D4381-F662-49F0-9CE1-E1099310D721 Q37506524-DBC0D8DA-EB2B-42C0-8147-580CD68E8E2F Q38053000-F8A14CEB-95A2-41B9-9E22-EC0F880D9D33 Q38724073-23A9718F-2813-4E29-BB44-B05E69241025 Q38792870-55A38380-E506-45B0-A3F3-60447402A198 Q38929509-1DA59FDB-2493-44BF-A774-2CA2700808D2 Q39044932-50E3870B-E791-4686-99AA-3119E8303D9E Q39514292-E3C61032-AE8C-43D1-9DEE-6D37F5BC2C83 Q39632553-3270E3D6-4D96-4A54-8C1D-DFDAAADD979A Q40112585-4F6E93B5-01E1-46A5-AE15-FF05FFD7BCB4 Q40184248-6FA5372C-3ED7-4279-9574-CC57BD3BECD4 Q40763975-C59C4C83-752C-4561-9FB6-439118066900 Q42024058-CD8F957B-8543-4232-B397-DD4424946426 Q42110234-90DC81BB-D605-4642-BDBA-334949F48F37 Q43003081-294E8314-110A-4844-B3D1-1A8592A657EA Q52707803-EA473CA0-FD84-42CE-9226-8893769576D5 Q53746587-5028B1D6-32F1-41A7-88E2-1A507B00AF87

P2860

First linezolid-resistant clinical isolates of Mycobacterium tuberculosis

http://www.wikidata.org/entity/Q35758951

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

First linezolid-resistant clinical isolates of Mycobacterium tuberculosis

@ast

First linezolid-resistant clinical isolates of Mycobacterium tuberculosis

@en

type

label

First linezolid-resistant clinical isolates of Mycobacterium tuberculosis

@ast

First linezolid-resistant clinical isolates of Mycobacterium tuberculosis

@en

prefLabel

First linezolid-resistant clinical isolates of Mycobacterium tuberculosis

@ast

First linezolid-resistant clinical isolates of Mycobacterium tuberculosis

@en

P1433

Q35758951-3DF55AF6-7415-4269-82F5-DA991CA649FA

P1476

Q35758951-E79198F1-8B2E-4F18-88B9-4DE0E44C73F9

P2093

Q35758951-7A513CC5-D71D-40D2-B0E9-88DF37543D9A

Q35758951-AFFF59B0-80D2-45E8-8404-5F158F961B22

Q35758951-B5448E61-040B-4A79-AE85-6CDEDC340AF8

P2860

Q35758951-0517E2F7-4BA9-4BDB-8B88-BA8674898C2B

Q35758951-1B3CDA79-C068-497E-981C-3C95866CDC46

Q35758951-25641F18-B4A9-41F2-92B9-6A2F681739A4

Q35758951-5B25865D-5EF4-4ECA-831D-0493C558C1F1

Q35758951-61C5ACD1-5153-42D0-8F7B-DC70045ECAF8

Q35758951-73235E85-1797-4251-BFF6-5AC6CF9A8534

Q35758951-8EA8E6DA-88FD-4DBB-8972-BCAFE2C4E43B

Q35758951-C8F144A0-4101-4741-AADA-05E41C6EE6E9

Q35758951-CB26D436-11F8-4820-BD86-FB271318671D

Q35758951-CD9E5E46-E3CB-4520-B5A7-1E9A01C17E96

P304

Q35758951-F2C85F82-F2B1-4CED-AF57-024DC04D1593

P31

Q35758951-D3DDA564-E1E9-4B67-B39D-8483F6ABF264

P356

Q35758951-7912F95A-535B-4262-B56E-3EFD1375529C

P407

Q35758951-D8588E69-9A1F-4838-8094-7D55F6BE3426

P433

Q35758951-03EB965F-EDCB-4E85-AD8F-8A06D09732BF

P478

Q35758951-072DE7F6-3EC6-4AC8-BF76-410CC936B117

P577

Q35758951-D2AF82A9-5E69-49AD-85D7-CE9AD1A80A5E

P5875

Q35758951-2C21D462-9B25-4BBF-9B52-0E5CD8FA3956

P698

Q35758951-A4D60289-BC9A-4EB0-A75D-3CFD65508EAE

P921

Q35758951-F88FEFAF-4985-4F7D-BFD8-FA6938E83A42

P932

Q35758951-7C0023F1-C64C-43C2-80C0-FA799A1092CC

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

First linezolid-resistant clinical isolates of Mycobacterium tuberculosis

@en

P2093

Doris Hillemann

http://www.w3.org/2001/XMLSchema#string

Elvira Richter

http://www.w3.org/2001/XMLSchema#string

Sabine Rüsch-Gerdes

http://www.w3.org/2001/XMLSchema#string

P2860

Mechanism of action of the oxazolidinone antibacterial agents

Molecular basis of intrinsic macrolide resistance in the Mycobacterium tuberculosis complex

mmpL7 gene of Mycobacterium tuberculosis is responsible for isoniazid efflux in Mycobacterium smegmatis

Oxazolidinone resistance mutations in 23S rRNA of Escherichia coli reveal the central region of domain V as the primary site of drug action.

Novel mechanism of resistance to oxazolidinones, macrolides, and chloramphenicol in ribosomal protein L4 of the pneumococcus

Rapid detection of Mycobacterium tuberculosis Beijing genotype strains by real-time PCR.

Multicenter laboratory validation of the BACTEC MGIT 960 technique for testing susceptibilities of Mycobacterium tuberculosis to classical second-line drugs and newer antimicrobials.

Oxazolidinones: a new class of antibacterials.

Oxazolidinones: activity, mode of action, and mechanism of resistance.

Pharmacokinetics and tissue penetration of linezolid following multiple oral doses.

P304

1534-1536

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.01113-06

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P577

2007-01-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6561223

http://www.w3.org/2001/XMLSchema#string

P698

17242139

http://www.w3.org/2001/XMLSchema#string

P921

Mycobacterium tuberculosis

P932

1855508

http://www.w3.org/2001/XMLSchema#string